Bioactivity of Natural Compounds: From Plants to Humans
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 9738
Special Issue Editor
Interests: diabetes mellitus; obesity; age-related diseases; advanced glycation end products (AGEs); medicinal plants; enzyme activity; pharmacokinetics; ADMET; pharmacotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bioactive natural compounds are secondary metabolites isolated from plants and marine organisms that can influence the human body and can also act as beneficial agents against disease. The use of isolated active compounds versus crude extracts allows one to define the precise dosage of the principle useful to induce efficacy. Studies on isolated compounds can support the use of natural products in traditional medicine and can drive the discovery of new active compounds that can be further developed as drugs.
Biologically active compounds are divided into three main classes, such as phenolic, terpene, and nitrogen compounds. Several compounds in these groups may be beneficial in cardiovascular diseases. Endothelial dysfunction is involved in several human diseases, including arteriosclerosis, arterial stiffness, vascular thrombosis and many others. Among all, soluble adhesion molecules, such as E-selectin, ICAM-1, and VCAM-1, and factors of the coagulation pathway, such as Willebrand factor and soluble thrombomodulin, in addition to various cytokines, such as IL-6, IL-8, IL-12, and C-reactive protein, are involved in vascular dysfunction. Furthermore, reactive oxygen species (ROS) and advanced glycation end products (AGEs) are implicated in tissue damages. Therefore, the search for new agents that can selectively inhibit markers of cardiovascular damage is especially interesting in the development of new drugs.
In this Special Issue, we welcome research articles and reviews on the identification of new active compounds of natural origin, as well as compounds already known for which new mechanisms of action or new activities are highlighted. Studies on natural compounds, both in vitro and in vivo, are of interest. In addition, clinical studies of natural compounds that focus on the effectiveness and adverse reactions in human subjects will be carefully examined.
Prof. Dr. Guglielmina Froldi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural compounds
- blood vessel
- endothelium dysfunction
- advanced glycation end products (AGEs)
- ROS
- cytokines
- ADMET properties
- pharmacokinetics
- gender difference
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.